3SBio Inc. (HKG:1530)
Hong Kong · Delayed Price · Currency is HKD 20.86
-0.38 (-1.79%)
At close: Mar 13, 2026
3SBio Market Cap
3SBio has a market cap or net worth of 52.1 billion as of March 13, 2026. Its market cap has increased by 238.77% in one year.
Market Cap
52.10B
Enterprise Value
49.95B
Revenue
9.94B
Ranking
n/a
PE Ratio
19.85
Stock Price
20.86
Market Cap Chart
Since June 11, 2015, 3SBio's market cap has increased from 22.67B to 52.10B, an increase of 129.84%. That is a compound annual growth rate of 8.04%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 13, 2026 | 52.10B | -13.73% |
| Dec 31, 2025 | 60.39B | 321.75% |
| Dec 31, 2024 | 14.32B | -20.61% |
| Dec 29, 2023 | 18.04B | -10.89% |
| Dec 30, 2022 | 20.24B | 23.46% |
| Dec 31, 2021 | 16.40B | -8.83% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sino Biopharmaceutical | 107.80B |
| Akeso | 102.34B |
| Sichuan Kelun-Biotech Biopharmaceutical | 90.48B |
| RemeGen | 63.24B |
| Shanghai Henlius Biotech | 36.77B |
| Biocytogen Pharmaceuticals (Beijing) | 35.97B |
| Shanghai Junshi Biosciences | 32.35B |
| TransThera Sciences (Nanjing) | 30.08B |